HARVARD BIOSCIENCE INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Harvard Bioscience Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Harvard Bioscience Inc Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 43.6M shares, a 2.18% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 43.6M +928K +2.18% Oct 31, 2024 10-Q 2024-11-08
Q2 2024 43.6M +923K +2.16% Jul 31, 2024 10-Q 2024-08-08
Q1 2024 43.4M +1.24M +2.94% Apr 30, 2024 10-Q 2024-05-07
Q3 2023 42.7M +1.03M +2.47% Oct 31, 2023 10-Q 2023-11-07
Q2 2023 42.7M +1.05M +2.53% Jul 31, 2023 10-Q 2023-08-08
Q1 2023 42.2M +960K +2.33% Apr 20, 2023 10-Q 2023-04-26
Q3 2022 41.7M +847K +2.08% Oct 31, 2022 10-Q 2022-11-09
Q2 2022 41.6M +874K +2.14% Jul 29, 2022 10-Q 2022-08-04
Q1 2022 41.2M +1.4M +3.53% Mar 7, 2022 10-K 2022-03-11
Q3 2021 40.8M +1.84M +4.71% Nov 1, 2021 10-Q 2021-11-05
Q2 2021 40.8M +1.82M +4.67% Jul 30, 2021 10-Q 2021-08-06
Q1 2021 39.8M +1.48M +3.85% Mar 5, 2021 10-K/A 2021-03-17
Q3 2020 39M +909K +2.39% Oct 30, 2020 10-Q 2020-11-06
Q2 2020 38.9M +897K +2.36% Jul 31, 2020 10-Q 2020-08-10
Q1 2020 38.3M +680K +1.81% Mar 6, 2020 10-K 2020-03-16
Q3 2019 38.1M +772K +2.07% Oct 30, 2019 10-Q 2019-11-08
Q2 2019 38M +1.47M +4.01% Aug 1, 2019 10-Q 2019-08-08
Q1 2019 37.7M +2.07M +5.82% Mar 7, 2019 10-K 2019-03-18
Q3 2018 37.3M +2.41M +6.92% Oct 25, 2018 10-Q 2018-11-01
Q2 2018 36.6M +1.74M +5.01% Jul 30, 2018 10-Q 2018-08-02
Q1 2018 35.6M +1.01M +2.93% Mar 9, 2018 10-K 2018-03-16
Q3 2017 34.9M +506K +1.47% Oct 27, 2017 10-Q 2017-11-02
Q2 2017 34.8M +522K +1.52% Jul 28, 2017 10-Q 2017-08-03
Q1 2017 34.6M +541K +1.59% Mar 7, 2017 10-K 2017-03-17
Q3 2016 34.4M +430K +1.27% Oct 28, 2016 10-Q 2016-11-03
Q2 2016 34.3M +387K +1.14% Jul 29, 2016 10-Q 2016-08-04
Q1 2016 34M +877K +2.65% Mar 21, 2016 10-K 2016-04-29
Q3 2015 33.9M +1.52M +4.7% Oct 30, 2015 10-Q 2015-11-05
Q2 2015 33.9M +1.63M +5.04% Jul 31, 2015 10-Q 2015-08-06
Q1 2015 33.2M +1.53M +4.82% Mar 6, 2015 10-K 2015-03-12
Q3 2014 32.4M +1.41M +4.55% Oct 31, 2014 10-Q 2014-11-06
Q2 2014 32.3M +1.6M +5.2% Aug 1, 2014 10-Q 2014-08-07
Q1 2014 31.6M +1.63M +5.43% Mar 7, 2014 10-K 2014-03-14
Q3 2013 31M +2.19M +7.59% Nov 1, 2013 10-Q 2013-11-08
Q2 2013 30.7M +1.91M +6.63% Aug 1, 2013 10-Q 2013-08-09
Q1 2013 30M +1.26M +4.37% Mar 8, 2013 10-K 2013-03-18
Q3 2012 28.8M +323K +1.14% Nov 1, 2012 10-Q 2012-11-08
Q2 2012 28.8M +304K +1.07% Aug 1, 2012 10-Q 2012-08-09
Q1 2012 28.8M Mar 8, 2012 10-K 2012-03-15
Q3 2011 28.5M Nov 1, 2011 10-Q 2011-11-09
Q2 2011 28.5M Aug 1, 2011 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.